{"id":"W4386271028","doi":"10.1016/s2152-2650(23)01446-5","title":"MM-372 A Phase III, Two-Stage, Randomized Study of Mezigdomide, Bortezomib, and Dexamethasone (MeziVd) Versus Pomalidomide, Bortezomib, and Dexamethasone (PVd) in Relapsed/Refractory Multiple Myeloma (RRMM): SUCCESSOR-1","year":2023,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Pomalidomide; Bortezomib; Dexamethasone; Multiple myeloma; Medicine; Internal medicine; Refractory (planetary science); Oncology; Materials science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001840112,0.002255168,0.003684055,0.0005789235,0.0005159294,0.001453319,0.001535422,0.001468353,0.008715058],"category_scores_gemma":[0.001327965,0.0009412168,0.002336356,0.0004752267,0.001414068,0.00087017,0.000527269,0.003673908,0.001758754],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001636309,"about_ca_system_score_gemma":0.002574784,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002983659,"about_ca_topic_score_gemma":0.006933525,"domain_scores_codex":[0.9992781,0.0003850018,0.00002610434,0.0001037639,0.0000463622,0.0001607191],"domain_scores_gemma":[0.9991954,0.0001789548,0.0001095571,0.00006257129,0.00003681306,0.0004166761],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.973496,0.008220932,0.0006535399,0.0002594409,0.0006596771,0.00002723887,0.00003802471,0.0004082445,0.002582441,0.0001705771,0.001051084,0.01243289],"study_design_scores_gemma":[0.9421438,0.0549724,0.001092864,0.00001952542,0.0003313823,0.00002389176,0.00001984976,0.0003107125,0.0003472282,0.0001779256,0.0005470678,0.00001326313],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9853913,0.004564811,0.0005424672,0.0009813627,0.0005094798,0.00285464,0.002037975,0.0001586072,0.002959522],"genre_scores_gemma":[0.9754205,0.003411736,0.002743701,0.002360776,0.000563504,0.00386718,0.003692305,0.00007322615,0.007866966],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008715058,"threshold_uncertainty_score":0.02915478,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07187944943131912,"score_gpt":0.405540219406015,"score_spread":0.3336607699746958,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}